1. Home
  2. CTS vs WVE Comparison

CTS vs WVE Comparison

Compare CTS & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTS
  • WVE
  • Stock Information
  • Founded
  • CTS 1896
  • WVE 2012
  • Country
  • CTS United States
  • WVE Singapore
  • Employees
  • CTS N/A
  • WVE N/A
  • Industry
  • CTS Electrical Products
  • WVE Biotechnology: Pharmaceutical Preparations
  • Sector
  • CTS Technology
  • WVE Health Care
  • Exchange
  • CTS Nasdaq
  • WVE Nasdaq
  • Market Cap
  • CTS 1.1B
  • WVE 915.6M
  • IPO Year
  • CTS N/A
  • WVE 2015
  • Fundamental
  • Price
  • CTS $39.18
  • WVE $8.09
  • Analyst Decision
  • CTS
  • WVE Strong Buy
  • Analyst Count
  • CTS 0
  • WVE 16
  • Target Price
  • CTS N/A
  • WVE $20.00
  • AVG Volume (30 Days)
  • CTS 265.1K
  • WVE 1.7M
  • Earning Date
  • CTS 07-24-2025
  • WVE 07-30-2025
  • Dividend Yield
  • CTS 0.41%
  • WVE N/A
  • EPS Growth
  • CTS 18.55
  • WVE N/A
  • EPS
  • CTS 2.11
  • WVE N/A
  • Revenue
  • CTS $520,937,000.00
  • WVE $93,946,000.00
  • Revenue This Year
  • CTS $3.90
  • WVE N/A
  • Revenue Next Year
  • CTS $6.50
  • WVE $4.55
  • P/E Ratio
  • CTS $18.53
  • WVE N/A
  • Revenue Growth
  • CTS 1.12
  • WVE N/A
  • 52 Week Low
  • CTS $34.02
  • WVE $5.04
  • 52 Week High
  • CTS $59.68
  • WVE $16.74
  • Technical
  • Relative Strength Index (RSI)
  • CTS 40.36
  • WVE 51.54
  • Support Level
  • CTS $38.32
  • WVE $7.93
  • Resistance Level
  • CTS $39.35
  • WVE $9.13
  • Average True Range (ATR)
  • CTS 1.17
  • WVE 0.53
  • MACD
  • CTS -0.19
  • WVE -0.06
  • Stochastic Oscillator
  • CTS 20.61
  • WVE 27.78

About CTS CTS Corporation

CTS Corp operates in the electronics industry. The company is a manufacturer of Sensors, Electronic components, and Actuators. It designs, manufactures, and sells a broad line of sensors, electronic components, and actuators mainly to original equipment manufacturers (OEM) for the aerospace and defense, industrial, information technology, medical, telecommunications, and transportation markets. Geographically, it derives a majority of its revenue from the United States and also has a presence in China; Singapore; the Czech Republic; Taiwan, Denmark, and other countries.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: